Drug Type Small molecule drug |
Synonyms sodium acetate |
Target |
Action agonists |
Mechanism HIF-2α agonists(Endothelial PAS domain-containing protein 1 agonists), Sodium supplements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (04 May 1983), |
Regulation- |
Molecular FormulaC2H4NaO2 |
InChIKeyBDKZHNJTLHOSDW-UHFFFAOYSA-N |
CAS Registry127-09-3 |
Start Date10 Jul 2024 |
Sponsor / Collaborator |
Start Date04 Jun 2024 |
Sponsor / Collaborator |
Start Date24 Apr 2024 |
Sponsor / Collaborator |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyponatremia | United States | 04 May 1983 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ischemia | Preclinical | - | - | 01 Apr 2023 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |